Korro Bio (KRRO) Total Current Liabilities (2018 - 2026)

Korro Bio (KRRO) has reported Total Current Liabilities for 9 consecutive years, with $12.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities fell 26.47% year-over-year to $12.6 million; the trailing twelve-month figure through Jun 2026 stood at $12.6 million (down 26.47% YoY), and the FY2025 full-year result was $11.9 million, down 20.21% from the prior year.
• Total Current Liabilities retreated to $12.6 million in Q2 2026 per KRRO's latest filing, from $14.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $22.0 million in Q1 2023 and bottomed at $8.3 million in Q2 2023.
• Historically, Total Current Liabilities has averaged $14.1 million across 5 years, with a median of $13.2 million in 2024.
• The widest YoY moves for Total Current Liabilities: up 123.92% in 2023, down 51.95% in 2023.
• Over 5 years, Total Current Liabilities stood at $8.7 million in 2022, then jumped by 123.92% to $19.5 million in 2023, then decreased by 23.22% to $15.0 million in 2024, then retreated by 20.21% to $11.9 million in 2025, then rose by 5.79% to $12.6 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $12.6 million, $14.8 million, and $11.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.